AcelRX Selling Off Sharply On FDA Reexamination By: Benzinga via Benzinga July 28, 2014 at 09:15 AM EDT Shares of AcelRx Pharmaceuticals (NASDAQ: ACRX) are selling off sharply monday morning after a blow from the FDA to ... Read More >> Related Stocks: Acelrx Pharmaceutica